Search Results - Ferran Pérez-Alcántara
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness analysis of dapagliflozin for the treatment of type 2 diabetes mellitus in Spain: results of the DECLARE-TIMI 58 study by Carlos Escobar, Cristóbal Morales, Margarita Capel, Susana Simón, Ferran Pérez-Alcántara, Elisenda Pomares
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book